Snegha Ananth, MD

NAME: Snegha Ananth MBBS
CAMPUS ADDRESS: University of Nebraska Medical Center
Division of Oncology/Hematology 986840 Nebraska Medical Center Omaha, NE 68198-6840
EDUCATION:
Medical School (MBBS):
Kilpauk Medical College
Dr. M.G.R University,
Tamil Nadu, Chennai, India
08/2009 – 05/2015
POST-DEGREE TRAINING:
Residency (Internal Medicine):
UT Health Science Center at San Antonio,
San Antonio, Texas, USA
07/2017 – 06/2020
Fellowship (Hematology-Oncology):
UT Health Science Center at San Antonio,
San Antonio, Texas, USA
07/2020 – 06/2023
Fellowship (Bone Marrow Transplantation and Cellular Therapy):
Stanford University
Palo Alto, CA, USA
07/2023 – 06/2024
ACADEMIC APPOINTMENTS (reverse chronological order, indicating years):
Assistant Professor of Medicine
Division of Oncology/Hematology
University of Nebraska Medical Center, Omaha, NE, USA 9/2024 – present
CERTIFICATIONS AND LICENSES:
American Board of Internal Medicine: Medical Oncology, 2023.
American Board of Internal Medicine: Hematology, 2023.
American Board of Internal Medicine: Internal Medicine, 2020.
Bachelor of Medicine & Bachelor of Surgery (MBBS), Kilpauk Medical College, India, 2015.
Nebraska Medical License: #36345
California Medical License: #A187589
HONORS AND AWARDS:
- Best Outgoing Student, Kilpauk Medical College, India, 2015
- Outstanding Intern of the Year, UT Health San Antonio, 2018
- ASH Merit Award, Poster walk special session, 2021
- ASCO Conquer Cancer Merit Award, 2022
- McDonald Award for Excellence in Cancer Research, 2022
MEMBERSHIPS AND OFFICES IN PROFESSIONAL SOCIETIES:
- American Society of Hematology.
- American Society of Transplantation and Cellular Therapy
COMMITTEE MEMBERSHIP:
National:
- Member, ASTCT Women and URG SIG committee fellow member, 2021-2024.
- Member, CIBMTR Working Committee Member – Lymphoma Working Committee, 2021-2024
BIBLIOGRAPHY
- Articles published in scholarly journals:
- Lee D, Goyal A, Wang WL, Ananth S, Lau E, Binkley MS, et al. Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B-cell lymphoma in an adolescent patient. eJHaem. 2024; 5: 153–156. https://doi.org/10.1002/jha2.859
- Gabriel Roman Souza, Zohra Nooruddin, Sophia Lee, Lauren Boyle, Kana Tai Lucero, Snegha Ananth, Kathleen Franklin, Michael Mader, Esteban Toro Velez, Amna Naqvi, Supreet Kaur, The Impact of Time From Diagnosis to Initiation of Chemotherapy on Survival of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health Administration, Clinical Lymphoma Myeloma and Leukemia, Volume 24, Issue 3, 2024, Pages e67-e77. https://doi.org/10.1016/j.clml.2023.11.003.
- Ta, Andrew, Supreet Kaur, Michael Mader, Kathleen Franklin, Ananth S, Madison Williams, Ryan Williams, Jean-Pierre Blaize, et al. 2024. “The Impact of Race and Ethnicity on Diffuse Large B-cell Lymphoma Outcomes within the Veterans Health Administration (VHA).” Leukemia & Lymphoma, April, 1-10. doi :10.1080/10428194.2024.2338856
- Patel SR, St Pierre F, Velazquez AI, Ananth S, Durani U, Anampa-Guzmán A, Castillo K, Dhawan N, Oxentenko AS, Duma N. The Matilda Effect: Underrecognition of Women in Hematology and Oncology Awards. Oncologist. 2021 Sep;26(9):779-786. PubMed Central PMCID: PMC8417845.
- Frei CR, Le H, McHugh D, Ryan K, Jones X, Galley S, Franklin K, Baus CJ, Tavera J, Janania- Martinez M, Gregorio D, Ananth S, Uribe R, Surapaneni P, Espinoza-Gutarra M, Song MM, Teng C, Obodozie-Ofoegbu OO, Nooruddin Z. Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration System. Leuk Lymphoma. 2021 Jul;62(7):1664- 1673. PubMed PMID: 33569992.
- Arora SP, Ananth S, Ketchum N, Gelfond J, Michalek J, Mahalingam D. The efficacy and safety of sorafenib in older adults with advanced hepatocellular carcinoma: An analysis of a majority Hispanic cohort. J Geriatr Oncol. 2020 Sep;11(7):1157-1160. PubMed PMID: 32273248.
- Ananth S, Sankaralingam R, Manoj M. Aggressive eosinophilic granulomatosis with polyangiitis and transverse sinus thrombosis. BMJ Case Rep. 2016 Jan 12;2016 PubMed Central PMCID: PMC4716382.
- Abstracts and Preliminary Communications:
- Snegha Ananth, Yi-Jiun Su, Mark P. Hamilton, Ne ha Agarwal, Wen-Kai Weng, Saurabh Dahiya, Sushma Bharadwaj, Jayasindhu Mallampet, Melody Smith, Katherine Ann Kong, Abigail Twoy, David B. Miklos, Matthew J. Frank; Post-CAR-T Minimal Residual Disease (MRD) Monitoring in Mantle Cell Lymphoma Enables Early Relapse Detection, Blood, Volume 142, Supplement 1, 2023, https://doi.org/10.1182/blood-2023-188338
- Sushma Bharadwaj, Eric Lau, Ayesha Hashmi, Mark P.Hamilton, Alexandria Jensen, Anmol Goyal, Mallika Marar, Caroline Lee, Snegha Ananth, Bita Sahaf, Jayasindhu Mallampet, Zachary Ehlinger, Shriya Syal, Sunita Patil, henry Guo, Melody Smith, Wen-Kai Weng, Matthew Frank, Michael Binkley, David Miklos, Saurabh Dahiya; Analysis of PET-CT Derived Radiomic Biomarkers with Efficacy, Dafety, and Expansion of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed or Refractory Large B cell Lymphoma (LBCL), Transplantation and Cellular Therapy, Volume 30, Issue 2, Supplement, S203, Feb 2024.
- Snegha Ananth, Supreet Kaur, Alaq Al-Abayechi, Jean Pierre Blaize, Lauren Diaz Boyle, Lakene Raissa Djoufack Djoumessi, Manuel Espinoza Gutarra, Kathleen Franklin, Lindsey Lu, Kana Tai Lucero, Phillip Nazarewicz, Abhishek Pandya, Gabriel Roman Souza, Michael M. Song, Brian Warnecke, Jennifer Whitehead, Madison H. Williams, Ryan A. Williams, Michael Mader, Zohra Nooruddin; Treatment Patterns and Survival Outcomes in Elderly Veterans Diagnosed with Diffuse Large B-Cell Lymphoma. Blood 2022; 140 (Supplement 1): 5195–5197. doi: https://doi.org/10.1182/blood-2022-171126
- Gabriel Roman Souza, Supreet Kaur, Lauren Diaz Boyle, Snegha Ananth, Kana Tai Lucero, Alaq Al-Abayechi, Jean Pierre Blaize, Lakene Raissa Djoufack Djoumessi, Manuel Espinoza Gutarra, Kathleen Franklin, Lindsey Lu, Phillip Nazarewicz, Abhishek Pandya, Michael M. Song, Brian Warnecke, Jennifer Whitehead, Madison H. Williams, Ryan A. Williams, Michael Mader, Zohra Nooruddin; The Impact of Time from Diagnosis to Initiation of Chemotherapy on Survival of Patients with Diffuse Large B-Cell Lymphoma in the Veteran`s Health Administration. Blood2022; 140 (Supplement 1): 2061–2062. doi: https://doi.org/10.1182/blood-2022-170576
- Lauren Diaz Boyle, Supreet Kaur, Gabriel Roman Souza, Snegha Ananth, Kana Tai Lucero, Alaq Al-Abayechi, Jean Pierre Blaize, Lakene Raissa Djoufack Djoumessi, Manuel Espinoza, Kathleen Franklin, Lindsey Lu, Phillip Nazarewicz, Abhishek Pandya, Michael M. Song, Brian Warnecke, Jennifer Whitehead, Madison H. Williams, Ryan A. Williams, Michael Mader, Zohra Nooruddin; Survival Outcomes for High Risk Primary Refractory and Relapsed Large B-Cell Lymphoma (LBCL) within the Veterans Health Administration (VHA). Blood 2022; 140 (Supplement 1): 9561–9563. doi: https://doi.org/10.1182/blood-2022-170661
- Impact of equal access by race and ethnicity on patients in the Veterans Health Administration (VHA) treated for diffuse large B-cell lymphoma (DLBCL). Snegha Ananth, Alaq Al-Abayechi, Jean-Pierre Blaize, Lauren Boyle, Raissa Lakene Djoufack Djoumessi, Manuel Ricardo Espinoza Gutarra, Kathleen Franklin, Lindsey Lu, Kana Lucero, Michael Mader, Phillip Nazarewicz, Zohra Nooruddin, Abhishek Pandya, Gabriel Roman Souza, Michael Meansup Song, Brian Warnecke, Jennifer Whitehead, Madison H. Williams, and Ryan A. Williams. Journal of Clinical Oncology 2022 40:16_suppl, 6526-6526
- Discovering disparities in diffuse large B-cell lymphoma (DLBCL): A hispanic population comparison between Florida and Texas. Ysaith Orellana, Carolina Velez-Mejia, Snegha Ananth, Qianqian Liu, Joel Michalek, and Adolfo Enrique Diaz Duque. Journal of Clinical Oncology 2022 40:16_suppl, e18562-e18562
- Gender and Racial Disparities in Faculty Rank and Leadership Positions Among Stem Cell Transplant Physicians in the United States. Snegha Ananth, Toka Amin, Nancelle Astride Loka Ndema, Nanda Beena Gopan, Kana Tai Lucero, Rhoshini Rajasekaran, Zohra Nooruddin, Transplantation and Cellular Therapy, Volume 28, Issue 3, Supplement, 2022, Pages S325-S326, https://doi.org/10.1016/S2666-6367(22)00578-4.
- Characteristics of Patients with Central Nervous System Relapse in Veterans with Diffuse Large B-Cell Lymphoma within the Veterans Health Administration. Amy M Horowitz, Madison H. Williams, Ryan A. Williams, Jean Pierre Blaize, Snegha Ananth, Michael M. Song, Brian Warnecke, Abhishek Pandya, Lakene Raissa Djoufack Djoumessi, Phillip Nazarewicz, Manuel Ricardo Espinoza-Gutarra, Juan J. Toro, Lindsey Lu, Kana Tai Lucero, Jennifer Whitehead, Kathleen Franklin, Michael Mader, Zohra Nooruddin. Blood 2021; 138 (Supplement 1): 2501.
- A Retrospective Study of Hospice Enrollment in Patients with Diffuse Large B Cell Lymphoma within the Veterans Health Administration. Kana Tai Lucero, Madison H. Williams, Ryan A. Williams, Snegha Ananth, Jean Pierre Blaize, Michael M. Song, Brian Warnecke, Abhishek Pandya, Lakene Raissa Djoufack Djoumessi, Phillip Nazarewicz, Manuel Ricardo Espinoza- Gutarra, Juan J. Toro, Lindsey Lu, Jennifer Whitehead, Kathleen Franklin, Michael Mader, Zohra Nooruddin. Blood 2021; 138 (Supplement 1): 2517.
- Ethnicity, Nativity and Outcomes in Burkitt Lymphoma Among US Hispanics: Texas and Florida State Database Study. Snegha Ananth, Ysaith Efren Orellana, Joel E Michalek, Qianqian Liu, Adolfo Enrique Diaz Duque. Blood Volume 138, Supplement 1, 2021, Page 4087, https://doi.org/10.1182/blood-2021-149981.
- Impact of Differences in Time from Diagnosis to Treatment on DLBCL Response and Survival Outcomes: A VA Study. Ryan A. Williams, Madison H. Williams, Jean Pierre Blaize, Snegha Ananth, David Gregorio, Gerardo Manuel Rosas, Michael M. Song, Brian Warnecke, Abhishek Pandya, Lakene Raissa Djoufack Djoumessi, Vivian Dee, Phillip Nazarewicz, Juan J. Toro, Kathleen Franklin, Michael Mader, Zohra Nooruddin. Blood 2020; 136 (Supplement 1): 1–2.
- Does Hispanic Origin Affect the Repartition and Outcome of Marginal Zone Lymphoma?. Lakene Raissa Djoufack Djoumessi, Snegha Ananth, Michael E Auster, Joel E Michalek, Qianqian Liu, Adolfo Enrique Diaz Duque; Blood 2020; 136 (Supplement 1): 12.
- Adverse event clusters present at dose-reduction in CLL patients on ibrutinib in the U.S. veterans Health Administration. Christopher R Frei, Kellie Ryan, Hannah Le, Daniel McHugh, Obiageri O Obodozie-Ofoegbu, Chengwen Teng, Xavier Jones, Samantha Galley, Kathleen Franklin, Juan Tavera, Michelle Janania Martinez, David Gregorio, Snegha Ananth, Ricardo Uribe, Prathibha Surapaneni, Manuel Ricardo Espinoza-Gutarra, Michael Song, and Zohra Nooruddin. Journal of Clinical Oncology 2020 38:29_suppl, 252-252
- Impact of Age on Treatment and Outcome in Newly Diagnosed DLBCL (Diffuse Large B-cell Lymphoma) Patients in the United States Veteran Population (2011-2017). Snegha Ananth, Madison H. Williams, Ryan A. Williams, Jean Pierre Blaize, David Gregorio, Michael M. Song, Gerardo Manuel Rosas, Lakene Raissa Djoufack Djoumessi, Brian Warnecke, Abhishek Pandya, Vivian Dee, Michael Mader, Juan J. Toro, Kathleen Franklin, Phillip Nazarewicz, Zohra Nooruddin. Blood 2020; 136 (Supplement 1).
- Demographic Differences in the Treatment and Mortality of Lymphoplasmacytic Lymphoma in Texas: Does Ethnicity Play Any Role?. Michael E Auster, Snegha Ananth, Lakene Raissa Djoufack Djoumessi, Qianqian Liu, Joel E Michalek, Adolfo Enrique Diaz Duque; Blood 2020; 136 (Supplement 1): 17–20.
- The Impact of Race and Ethnicity on Diffuse Large B-Cell Lymphoma (DLBCL) Outcomes within the Veterans Health Administration (VHA). Madison H. Williams, Ryan A. Williams, Jean Pierre Blaize, Snegha Ananth, David Gregorio, Gerardo Manuel Rosas, Michael M. Song, Brian Warnecke, Abhishek Pandya, Lakene Raissa Djoufack Djoumessi, Vivian Dee, Phillip Nazarewicz, Kathleen Franklin, Juan J. Toro, Michael Mader, Zohra Nooruddin. Blood 2020; 136 (Supplement 1): 3–4.
- Never too young: Retrospective study on age and racial disparity in the outcome of primary CNS Lymphoma in south Texas. Snegha Ananth, Michelle Janania Martinez, Juan Garza, Prathibha Surapaneni, Tyler William Snedden, David Gregorio, Sushanth Kakarla, Jeremy Rawlings, Joel Michalek, Qianqian Liu, and Adolfo Enrique Diaz Duque. Journal of Clinical Oncology 2020 38:15_suppl, e14553-e14553
- Hodgkin Lymphoma Outcomes: Can we expect ethnic parity in a Hispanic Prevalent Population?. Michelle Janania Martinez, Prathibha Surapaneni, Juan F Garza, Tyler W Snedden, Snegha Ananth, Jeremy Rawlings, David J Gregorio, Sushanth Kakarla, Qianqian Liu, Joel E Michalek, Adolfo Enrique Diaz; Blood (2019) 134 (Supplement_1): 4056
- Does Insurance Status Interfere with Outcomes in Patients with Hodgkin and Non-Hodgkin Lymphoma? The UT Health San Antonio Experience. Juan F Garza, Michelle Janania Martinez, Prathibha Surapaneni, Tyler W Snedden, Snegha Ananth, David J Gregorio, Sushanth Kakarla, Jeremy Rawlings, Joel E Michalek, Qianqian Liu, Adolfo Enrique Diaz; Blood (2019) 134 (Supplement_1): 2141
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:04/03/2025Date updated:04/03/2025